UNSPSC 51101694: Tosulur

This classification denotes an antiprotozoal agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier I04MF82GW9. European Medicines Agency schedules Tosulur in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB11202MIG. Tosulur generally arises in the molecular formula C11H15NO5S.

The term TOSULUR is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 38, no. 6, 1984, list 24.) TOSULUR is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule tosulur under HS 29350090 and SITC 51580. As of Q4 2014, TOSULUR remains the US FDA Preferred Term for this commodity. Tosulur bears US NLM identifiers UMLS ID C2699972 and NCI Concept Code C76434. SMILES: CC1=CC=C(C=C1)S(=O)(=O)NC(=O)OCCOC.

UNSPSC 51101694 Tosulur is a Commodity code under which state and local governments procure pharmaceutical products and medical countermeasures for public health and emergency preparedness. The recent solicitations tagged under this code show procurement of specific antimicrobial medications (Doxycycline Hyclate and Ciprofloxacin Hydrochloride) and opioid overdose reversal agents (Naloxone) alongside associated medical equipment and disposal systems. The issuing bodies include state health departments and county health authorities pursuing pharmaceutical warehouse contracts and community health initiatives. These procurements typically move through competitive bidding processes (ITB/IFB channels) and often leverage cooperative purchasing vehicles such as multi-state pharmaceutical consortia (MMCAP Infuse in the Illinois example).

The Illinois Department of Public Health and Seminole County, Florida represent the recent activity under this code. The Illinois Department of Public Health awarded a $2,999,999.11 piggyback pharmaceutical warehouse contract through the MMCAP Infuse cooperative to Chartwell Rx LLC on August 28, 2026 for a 12-month initial term with two renewal options, sourcing Doxycycline Hyclate 100mg and Ciprofloxacin Hydrochloride 500mg tablets. Seminole County, Florida issued an IFB (26459723LAS) with a July 26, 2023 response deadline for 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida. Vendors must include all shipping and delivery costs in proposals and meet E-Verify and drug-free workplace compliance. Activity documented under this code spans Florida and Illinois; broader geographic distribution is not supported by the recent opportunities block.